DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Synagis (Palivizumab) - Reports of Side Effects & Adverse Reactions

Synagis Rx
Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Other Rx Information Active Ingredients Adverse Event Reports
 

Synagis News
News in Media Published Studies Curr't Clinical Trials



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Synagis (Palivizumab). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (333)
     Bronchiolitis (105),  Respiratory Disorder (33),  Asthma (25), more >>

Cases resulting in a serious event (327)
     Bronchiolitis (105),  Respiratory Disorder (33),  Asthma (24), more >>

Cases resulting in death (41)
     Aspiration (5),  Respiratory Syncytial Virus Infection (4),  Cardio-Respiratory Arrest (4), more >>

Cases resulting in life threatening events (8)
     Condition Aggravated (2),  General Physical Health Deterioration (2),  Pyrexia (2), more >>

Cases resulting in hospitalization (289)
     Bronchiolitis (104),  Respiratory Disorder (32),  Asthma (24), more >>

Cases resulting in disability (1)
     Conjunctivitis (1),  Respiratory Distress (1),  Respiratory Syncytial Virus Infection (1), more >>

Cases resulting in other serious reactions (19)
     Shock (4),  Respiratory Syncytial Virus Infection (3),  Pneumonia (2), more >>

Below is a sample of reports where side effects / adverse reactions may be related to Synagis (Palivizumab). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 3 month old female receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-31

Patient: 3 month old female

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-08
    End date: 2007-01-09

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-08

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-05

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-13

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-20


Adverse event in 11 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-31

Patient: 11 month old male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31
    End date: 2006-11-28

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-21

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-17

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-15


Adverse event in 6 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-31

Patient: 6 month old male, weighing 4.4 kg (9.7 pounds)

Adverse reactions / side effects: Bronchopneumonia, Bronchiolitis, Respiratory Syncytial Virus Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-10
    End date: 2006-11-07

Synagis
    Dosage: 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-10

Synagis
    Dosage: 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-09

Synagis
    Dosage: 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-13


Adverse event in 3 month old female receiving Synagis (Palivizumab)

Reported by a physician from Japan on 2007-10-31

Patient: 3 month old female

Adverse reactions / side effects: Platelet Count Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis (Palivizumab)

Other drugs received by patient: Furosemide; Spironolactone; Ferric Pyrophosphate Soluble


Adverse event in 4 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-31

Patient: 4 month old male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-17
    End date: 2007-02-06

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-21

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-09

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-06


Adverse event in 2 month old female receiving Synagis (Palivizumab)

Reported by a physician from Japan on 2007-10-29

Patient: 2 month old female

Adverse reactions / side effects: Conjunctivitis, Fungal Skin Infection, Bronchitis, Respiratory Syncytial Virus Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-02
    End date: 2006-11-30

Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-02

Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-27

Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-24

Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-27

Synagis
    Dosage: see image, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-27

Other drugs received by patient: Furosemide; Cefapene Pivoxil Hydrochloride Hydrate (Cefcapene Pivoxil Hydrochlorid; Ferric Pyrophosphate (Ferric Pyrophosphate)


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-29

Patient: male

Adverse reactions / side effects: Laryngeal Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-02
    End date: 2006-10-02

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-15

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-09

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-12


Adverse event in 14 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-29

Patient: 14 month old male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31
    End date: 2006-11-28

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-21

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-16

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-15


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-29

Patient: male, weighing 4.4 kg (9.6 pounds)

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-30
    End date: 2006-10-30

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-05

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-08

Synagis
    Dosage: intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-12


Adverse event in 9 month old female receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-29

Patient: 9 month old female

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-24
    End date: 2006-11-21

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-24

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-28

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-20


Adverse event in 5 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-29

Patient: 5 month old male, weighing 4.7 kg (10.3 pounds)

Adverse reactions / side effects: Aspiration, Bronchitis, Respiratory Syncytial Virus Infection

Adverse event resulted in: life threatening event

Suspect drug(s):
Synagis
    Dosage: 70 mg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-04
    End date: 2006-12-04

Synagis
    Dosage: 70 mg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-08

Synagis
    Dosage: 70 mg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-15


Adverse event in 6 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: 6 month old male

Adverse reactions / side effects: Bronchiolitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-29
    End date: 2007-03-01

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-29

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-30

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-31


Adverse event in female receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: female

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Synagis (Palivizumab)


Adverse event in 2 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: 2 month old male, weighing 3.0 kg (6.6 pounds)

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-23
    End date: 2007-02-20

Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-23

Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15 mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-20


Adverse event in 12 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: 12 month old male, weighing 1.5 kg (3.3 pounds)

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis (Palivizumab)


Adverse event in 7 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: 7 month old male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-09
    End date: 2007-02-01

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-09

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-07

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-04

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-01


Adverse event in 5 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: 5 month old male, weighing 5.6 kg (12.3 pounds)

Adverse reactions / side effects: Bronchiolitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-09
    End date: 2007-03-09

Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-09

Synagis
    Dosage: 15 mg/kg, intramuscular, 15 mg/kg, intramuscular, 15mg/kg, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-13


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-07
    End date: 2007-01-08

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-07

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-12

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-15


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-24

Patient: male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-22
    End date: 2006-12-22

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-24

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-03


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-22

Patient: male

Adverse reactions / side effects: Bronchiolitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg, intramuscular, intramuscular, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-12
    End date: 2006-12-12

Synagis
    Dosage: 15 mg/kg, intramuscular, intramuscular, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-09

Synagis
    Dosage: 15 mg/kg, intramuscular, intramuscular, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-06

Synagis
    Dosage: 15 mg/kg, intramuscular, intramuscular, intramuscular
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-16


Adverse event in 14 month old female receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-22

Patient: 14 month old female

Adverse reactions / side effects: Respiratory Tract Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-07
    End date: 2007-02-13

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-07

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-13

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-10

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-13


Adverse event in male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-22

Patient: male

Adverse reactions / side effects: Respiratory Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-25
    End date: 2006-10-25

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-22

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2006-12-29

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-29

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-13


Adverse event in 2 month old male receiving Synagis (Palivizumab)

Reported by a physician from Japan on 2007-10-22

Patient: 2 month old male

Adverse reactions / side effects: Respiratory Failure, Condition Aggravated, General Physical Health Deterioration

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Synagis
    Dosage: see image
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-17
    End date: 2006-12-21

Synagis
    Dosage: see image
    Indication: Antiviral Prophylaxis
    Start date: 2006-11-17

Synagis
    Dosage: see image
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-24

Synagis
    Dosage: see image
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-22

Synagis
    Dosage: see image
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-23

Other drugs received by patient: Ferric Pyrophosphate (Ferric Pyrophosphate); Furosemide; Spironolactone; Levothyroxine Sodium Hydrate (Levothyroxine Sodium); Midazolam HCL; L-Carbocisteine (Carbocisteine); Pranlukast Hydrate (Pranlukast); Clarithromycin


Adverse event in 5 month old female receiving Synagis (Palivizumab)

Reported by a individual with unspecified qualification from Belgium on 2007-10-22

Patient: 5 month old female, weighing 3.5 kg (7.7 pounds)

Adverse reactions / side effects: Vomiting, Pneumonia, Rhinorrhoea, Pallor, Fluid Intake Reduced, Sneezing, Apnoea, Shock, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-11
    End date: 2007-01-11

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-02-06

Synagis
    Indication: Antiviral Prophylaxis
    Start date: 2007-03-08


Adverse event in 3 month old male receiving Synagis (Palivizumab)

Reported by a physician from Belgium on 2007-10-22

Patient: 3 month old male

Adverse reactions / side effects: Bronchiolitis, Sudden Infant Death Syndrome

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31
    End date: 2006-11-28

Synagis
    Dosage: 15 mg/kg
    Indication: Antiviral Prophylaxis
    Start date: 2006-10-31

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009